Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin people.”
Carbonated Water Could Boost Weight Loss, New Study Suggests
· 2d · on MSN
What you should know about carbonated water and weight loss
· 2d · on MSN
Carbonated Water 'May Promote Weight Loss,' According to New Study
What to know about sparkling water and weight loss, according to new study
To break down the study's findings, ABC News chief medical correspondent Dr. Tara Narula joined "Good Morning America" on Wednesday and explained that for those looking to carbonated water to support weight loss, the "clinical effect is very, very small -- it might help, but is really probably not clinically relevant."
Don't expect to shed pounds solely due to your choice of beverage. The benefits of drinking carbonated water for weight loss are “so small that it is difficult to expect weight loss effects solely from the CO2 in carbonated water,” the study notes.
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the medication Lexapro
If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your healthcare provider might prescribe an antidepressant to control your symptoms and help you recover.
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a significant weight reduction compared with placebo, according to top-line results from a phase 1b/2a trial.
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 products, by mimicking a hormone in the body that provides a satiated feeling and curbs hunger, but adds a different hormone in the pancreas.
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.
One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.
Investor's Business Daily on MSN1h
Novo Nordisk Surges As Next-Gen Obesity Drug OutperformsNovo Nordisk stock surged Friday after the obesity kingpin reported strong results for its next-generation weight-loss drug, amycretin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback